Clinical Trial Update: This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 Cream [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MC2-01 Cream for psoriasis vulgaris has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• MC2-01 Cream

Snippet

Sponsor: MC2 Therapeutics | Conditions: Psoriasis Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-11-27